2014 international pharmaceutical innovation cooperation forum held in Beijing longchong

Source: China Council for the promotion of medicine 2014-10-29 sponsored by the national health and Family Planning Commission of the people's Republic of China (hereinafter referred to as the national health and Family Planning Commission) and organized by the China Council for the promotion of pharmaceutical innovation (hereinafter referred to as the China Council for the promotion of pharmaceutical innovation) "2014 International Pharmaceutical Innovation Cooperation Forum - challenges and opportunities facing BRICs countries" from October 27 to 28, 2014 The day was held in Beijing Ren Minghui, director of the International Cooperation Department of the national health and Family Planning Commission, Valdemar Carneiro Leao, ambassador extraordinary and Plenipotentiary of the Embassy of the Federal Republic of Brazil in China, Bernhard Schwartlander, who representative in China, mariangela Simao, director of human rights, gender, prevention and mobilization, UNAIDS , sun piaoyang, President of China pharmaceutical promotion association, song Ruilin, executive chairman, and representatives of BRICs pharmaceutical colleagues, members of the association, scholars and relevant organizations attended the forum On the afternoon of the 27th meeting, the opening ceremony of the forum was held, chaired by Ren Minghui, director of the International Cooperation Department of the national health and Family Planning Commission Valdemar Carneiro Leao, ambassador extraordinary and Plenipotentiary of the Embassy of the Federative Republic of Brazil in China, Bernhard Schwartlander, representative of the World Health Organization in China, mariangela Simao, director of human rights, gender, prevention and mobilization, UNAIDS, and sun piaoyang, President of the Chinese Association for the promotion of drugs delivered speeches respectively Liu Qian, deputy director of the national health and Family Planning Commission, was unable to attend due to official business Director Ren Minghui read the opening speech on behalf of him Ren Minghui, director of the International Cooperation Department of the national health and Family Planning Commission, presided over the opening ceremony of the forum Liu Qian, deputy director of the forum, pointed out that health issues are not only important public products that affect the health, economic development and social stability of people in a country and region, but also an embodiment of the common interests of the global people, and an important part of the global development agenda BRICs countries have laid a solid foundation for pharmaceutical innovation and R & D in order to further promote cooperation in this field, they put forward the following cooperation initiatives: exchange pharmaceutical innovation policies, promote multi-party innovation cooperation, participate in global health actions, and give full play to the advantages of industry associations Valdemar Carneiro Leao, ambassador extraordinary and Plenipotentiary of the Embassy of the Federative Republic of Brazil in China, Bernhard Schwartlander, representative of the World Health Organization in China, mariangela Simao, director of human rights, gender, prevention and mobilization, UNAIDS, and sun piaoyang, President of the Chinese Association for the promotion of drugs delivered speeches respectively Valdemar Carneiro Leao pointed out that the population of BRICs countries accounts for more than 43% of the global population, while the land area accounts for more than 1 / 4 of the global land area Regional diversity has an important impact on health To establish an innovative and sustainable framework to promote drug R & D and technology transfer in BRICs countries, it is essential to strengthen experience sharing and exchange Bernhard Schwartlander said that strengthening cooperation in the field of medicine and health in BRICs countries is a great changing force for the future development of public health in the world Mariangela Simao pointed out that balancing the relationship between the price, accessibility and innovation of drugs is of great significance for promoting the pharmaceutical and health undertakings in developing countries Sun piaoyang pointed out that China has become a typical representative of the global emerging pharmaceutical market, and hoped to find the policy improvement channels and international cooperation modes and opportunities to promote the innovative development of BRICs pharmaceutical industry through this forum Valdemar Carneiro Leao, ambassador extraordinary and Plenipotentiary of the Embassy of the Federative Republic of Brazil in China delivered a speech; Shi Hede, representative of the World Health Organization in China delivered a speech; mariangela Simao, director of human rights, gender, prevention and mobilization of UNAIDS delivered a speech; sun piaoyang, President of the China Association for the promotion of drugs delivered a speech; deputy director of the Department of medicine regulatory compliance management of the Ministry of health of South Africa Thamizhanban Pillay made a report on the theme of "development of South Africa's pharmaceutical industry and policies to encourage innovation and development of the pharmaceutical industry" Mr Pillay first thanked the health and Family Planning Commission, the host of the meeting, and the China Council for the promotion of drugs, the host of the meeting Based on the promotion of BRICs pharmaceutical innovation cooperation, countries should deepen their understanding and understanding of each other, which is the prerequisite for good cooperation So the report introduces the statistics and medical policies of South Africa in the field of health, how to realize medical innovation and two institutions that play an important role in it: Medical Research Committee and BIOVAC Thamizhanban Pillay, deputy director of the Department of medical regulatory compliance management of the Ministry of health of South Africa, made a report on "the development of the pharmaceutical industry in South Africa and the policies to encourage the innovation and development of the pharmaceutical industry" Zhang Yongxiang, a researcher of the Academy of Military Medical Sciences of the people's Liberation Army, made a report on "the focus and future trend of new drug research and development supported by China" The theme report focuses on three aspects: new drug research and development supported by China; major new drug creation, major science and technology projects; and the future development trend of new drugs in China The R & D foundation of China's pharmaceutical industry is weak Since the reform and opening up, the government has increased its support to it In order to prevent and control major diseases, the state has carried out major new drug development projects and promoted R & D innovation In general, the future of new drug research and development in China is facing great opportunities and challenges To meet the challenges, we need to speed up the implementation of special projects and the combination of industry, University and research, improve the level of research and development, further optimize the industrial environment, and strengthen international cooperation, especially among BRICs countries Zhang Yongxiang, researcher of the Academy of Military Medical Sciences of the people's Liberation Army, made a report Jorge Bermudez, vice chairman of the fiocruz foundation of the Ministry of health of Brazil, made a report on the theme of "the development of the pharmaceutical industry in Brazil and relevant policies to encourage innovation in the pharmaceutical industry" Industrial policy is of great political significance and priority to public health in Brazil Jorge introduced the basic situation of Brazil's pharmaceutical industry and Brazil's proud international cooperation, typically South South cooperation The encouragement of policies and mutual certification of quality standards are all worthy of learning in practice Jorge Bermudez, vice president of the fiocruz foundation of the Brazilian Ministry of health, made a report After the three speakers finished their speeches, they had a warm interaction with the audience on the topics of fighting Ebola and seeking in-depth cooperation among enterprises At present, Brazil, South Africa and China have carried out corresponding research to fight the Ebola epidemic In order to cope with the global health crisis, it is necessary to strengthen cooperation The industry associations of various countries have built a good platform for communication and cooperation among pharmaceutical enterprises Enterprises should use this platform to better achieve win-win cooperation The "2014 International Pharmaceutical Innovation Cooperation Forum" continued to be held on the morning of the 28th interactive discussion The morning meeting is divided into two stages The first stage is presided over by song Ruilin, executive chairman of China Pharmaceutical Association Song Ruilin, executive chairman of China Association for the promotion of drugs, presided over the first phase of the conference Sun he, vice president of Tianshi Group Co., Ltd., made a report entitled "innovative research and development experience of traditional Chinese drugs and international cooperation" The report shows the progress of clinical trials of Compound Danshen Dropping Pills in the United States at present, and emphasizes that the experimental design should reflect the advantages of botanical drugs, make up for the shortage of chemical drugs, fill the blank market of children's drugs, and realize the symptomatic treatment of difficult and miscellaneous diseases such as gynecological diseases We also call on the BRICs regulatory agencies to strengthen cooperation, reach a good consensus on the use and efficacy of traditional Chinese medicine and herbal medicine, form a recognized system for each other, and accelerate the research, development, use and development of traditional Chinese medicine and herbal medicine Sun he, vice president of Tianshili Group Co., Ltd., made a report Klara tisoki, head of the Department of essential drugs and health technology in the Western Pacific region of the World Health Organization, made a report on the theme of "challenges to global public health and the role of who in promoting pharmaceutical innovation cooperation" According to the report, the global burden of disease affects research and development needs Moreover, there are different degrees of gaps in the accessibility of drugs in various countries, and pharmaceutical innovation is facing challenges and obstacles Therefore, we should consider creating innovative drug financing mechanism, risk sharing mechanism, providing evidence to prove the value of drugs, and playing the role of the World Health Organization At the same time, it puts forward common requirements for the participating countries, how to identify and provide medical needs, and how to achieve effective cooperation between countries Klara tisocki, head of the Department of essential drugs and health technology of the Western Pacific region of the World Health Organization, made a report Mariangela Simao, director of human rights, gender, prevention and mobilization of UNAIDS, made a report on the theme of "global AIDS epidemic trend and the significance of pharmaceutical innovation and cooperation for AIDS prevention and control" This paper introduces the current situation of AIDS with a series of data and how medical innovation plays a role in the prevention and treatment of AIDS The report states that the disease burden of AIDS is mainly concentrated in BRICs countries, and the cost of preventive spending takes the disease burden and income into account We should give full play to the community-based responsibility sharing model, the construction of the common pricing mechanism platform that Brazil and South Africa have participated in, and the quality control mechanism within and outside BRICs Mariangela Simao, director of human rights, gender, prevention and mobilization of UNAIDS, made a report on the second stage, which was chaired by Xing Ruoqi, researcher of the major special department of science and education of the national health and Family Planning Commission Xing Ruoqi, researcher of major special department of science and Education Department of national health and Family Planning Commission, presided over the second level meeting Zhang Lianshan, deputy general manager of Jiangsu Hengrui Pharmaceutical Co., Ltd., made a report entitled "innovative R & D experience and international cooperation of Chinese chemical drugs" The demand for medicine in emerging markets is growing In order to realize the innovation and R & D of medicine, make full use of China's unique innovation environment, especially the rich clinical resources, seize the market opportunities and policy opportunities for the development of medicine innovation, and adopt the differentiated innovation strategy to successfully realize the transformation of enterprises Zhang Lianshan, deputy general manager of Jiangsu Hengrui Pharmaceutical Co., Ltd made a report Eduardo Jorge Valadares Oliveira, director of the industrial park and innovation science and Health Department of the Secretariat of science, technology and strategy of the Ministry of health of Brazil, made a report on the theme of "Brazil's experience in pharmaceutical research and development and international cooperation" First of all, it introduces the medical and health services in Brazil, organizes national resources to carry out health technology assessment, national clinical trial network, cancer clinical trials and other research, and specifically introduces how Brazil carries out international cooperation Eduardo Jorge Valadares Oliveira, director of the Ministry of science, technology and strategy Secretariat of the Ministry of health of Brazil, made a report The speakers and audience made in-depth discussions on the compliance of children's drug use, the contradiction between medical needs and costs, the prevention and treatment of infectious diseases, and major innovation projects By changing the dosage form and considering different delivery systems, children's drug compliance can be improved; in terms of balancing drug demand and high research and development costs, who In terms of the prevention and treatment of infectious diseases, adequate information support and standardized group training and education are crucial At the end of the interactive discussion, Zhang Yang, deputy director of the International Cooperation Department of the national health and Family Planning Commission, read out the "2014 International Pharmaceutical Innovation Cooperation Forum initiative on promoting BRICs pharmaceutical innovation cooperation"